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Abstract Phosphorylation of anti-viral nucleoside analogs by
mitochondrial thymidine kinase 2 (TK2) has been implicated as a
mechanism for the mitochondrial toxicity caused by several of
these compounds. We have cloned the cDNA of mouse TK2 and
shown that the enzyme is targeted to the mitochondria when
expressed in fusion with the green fluorescent protein. This is the
first report on the cloning of a mitochondrial TK2 and will
contribute to elucidate the role of TK2 in the pharmacological
activation of nucleoside analogs.
z 1999 Federation of European Biochemical Societies.
Key words: Nucleoside analog; Nucleoside kinase;
Mitochondrial toxicity; Anti-viral therapy;
Mitochondrial import signal
1. Introduction
Several pyrimidine nucleoside analogs are potent inhibitors
of viral replication. These analogs include 3P-azido-2P,3P-di-
deoxythymidine (AZT), 2P,3P-dihydro-2P,3P-dideoxythymidine,
2P,3P-dideoxycytidine and 2P-deoxy-3P-thiacytidine, that are
used in therapy of HIV infection. Pyrimidine nucleoside ana-
logs are also active towards hepatitis B and C virus infections
and investigations to elucidate their role in anti-hepatitis ther-
apy are currently initiated.
Nucleoside analogs are transported into cells by nucleoside
transporters and become phosphorylated intracellularly to
their triphosphate derivatives by nucleoside and nucleotide
kinases [1]. The nucleoside analog triphosphates subsequently
inhibit the viral polymerases that replicate the viral genome.
Although the nucleoside analogs preferentially inhibit viral
polymerases, they also interfere to some extent with cellular
DNA replication. Inhibition of nuclear DNA replication
causes cell cycle arrest or cell death, resulting in adverse clin-
ical e¡ects such as anemia, neutropenia and gastrointestinal
disturbances. In addition to interfering with nuclear DNA
replication, certain pyrimidine nucleoside analogs also inter-
fere with replication of mitochondrial DNA [2]. Mitochon-
drial DNA damage, and subsequent mitochondrial dysfunc-
tion, induced by nucleoside analogs ranges from mild
myopathy and neuropathy to severe multi-organ failure [2].
Mitochondrial DNA replication, catalyzed by DNA poly-
merase Q, is performed in the mitochondrial matrix. Nucleo-
side analogs that interfere with this process must therefore be
present in this subcellular compartment. The inner mitochon-
drial membrane prevents free transport of nucleotides between
the cytosol and the mitochondrial matrix. This separates the
mitochondrial deoxyribonucleotide pool from the cytosolic/
nuclear pool [3,4]. Mammalian cells contain two di¡erent thy-
midine kinases that phosphorylate thymidine and uridine nu-
cleoside analogs [3,5^7]. The nucleoside kinases, named thy-
midine kinase 1 and 2 (TK1 and TK2), are located in the
cytosol and mitochondria, respectively [4,7]. The existence of
a mitochondrial thymidine kinase has lead to the hypothesis
that the mitochondrial location of this enzyme is correlated to
the mitochondrial DNA damage caused by several pyrimidine
nucleoside analogs.
We have previously cloned the cDNA of human TK2 [8].
However, the predicted amino acid sequence did not exhibit
properties of a mitochondrial import signal and the enzyme
was not targeted to mitochondria when expressed in mamma-
lian cells [9]. Recently, Wang and co-workers reported the
cloning of a human TK2 that di¡ered in the N-terminal re-
gion from the previously cloned cDNA, although it was trun-
cated and lacked a translation start codon [10]. The complete
cDNA sequence of a mitochondrial TK2 is thus not known,
which prevents further studies on the role of this enzyme for
the activation of nucleoside analogs in vivo. In the present
study, we report the cloning of a mouse TK2 cDNA. The
N-terminal predicted amino acid sequence of this protein
had properties similar to those of a mitochondrial import
signal and we further showed that the enzyme is targeted to
mitochondria when overexpressed in mammalian cells.
2. Materials and methods
2.1. Cloning of mouse TK2 cDNA
We searched the expressed sequence tag (EST) library of the Gen-
Bank database at the National Institute for Biotechnology Informa-
tion (http://www.ncbi.nlm.nih.gov/) with the Basic Local Alignment
Search Tool [11] to identify murine cDNA clones homologous to
human TK2. EST clones were obtained from Research Genetics
(Huntsville, AL, USA). The complete DNA sequences of the clones
were determined using the BigDye terminator sequencing kit (Perkin-
Elmer) and an ABI310 automated DNA sequencer.
Rapid ampli¢cation of cDNA ends PCR was used to clone the
lacking 5P-cDNA region from a mouse liver cDNA library (Marathon
Ready cDNA, Clontech). The Advantage-GC Genomic PCR mix
(Clontech) was used according to the manufacturer’s protocol and
PCR primers were designed based on the EST cDNA sequence (5P-
CCCAGCCTGTGCTGTGCTTCTCCAGGGTAT and 5P-AGTCA-
ACCTCGGGCATCTTCCCACTTCTAT). The ampli¢ed DNA frag-
ment was cloned into the pGEM-T plasmid vector (Promega) and the
DNA sequence was determined as described above.
2.2. Construction of green £uorescent protein (GFP) plasmid vectors
The open reading frame of mouse TK2 cDNA was PCR-ampli¢ed
with primers containing engineered 5P-EcoRI sites (5P-ACAGAATT-
CACCATGCTGCTGCGGTCGCTGCGT and 5P-ACAGAATTCG-
TCCATGCTTCCAGTTCTCTGG) and the cDNA fragment was
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cloned into the EcoRI site of the pEGFP-N1 vector (Clontech). The
cDNA sequence encoding the 31 amino acids N-terminal mitochon-
drial import signal of cytochrome c oxidase subunit VIII (cytC) was
cloned upstream of GFP to create the cytC-GFP fusion [12]. The
plasmids were puri¢ed with the NucleoSpin kit (Clontech) and their
sequences veri¢ed by DNA sequencing.
2.3. Culture and transfection of cell lines
A Chinese hamster ovary (CHO) cell line was obtained from the
American Type Culture Collection. The cells were cultured at 37‡C in
McCoy 5A modi¢ed medium supplemented with 10% (v/v) fetal calf
serum (Gibco BRL), 100 U/ml penicillin and 0.1 mg/ml streptomycin.
The cells were transfected using Lipofectamine (Gibco BRL) as de-
scribed in the Gibco protocol and GFP £uorescence was visualized in
the living cells 24 h after transfection by £uorescence microscopy [9].
3. Results
3.1. Cloning of mouse mitochondrial TK2 cDNA
We used the sequence of the cloned human TK2 cDNA
[8,10] to search the GenBank EST sequence library to identify
mouse TK2 cDNA clones. Several mouse EST clones W95%
identical to human TK2 were identi¢ed. An EST clone de-
rived from a mouse macrophage cDNA library (IMAGE
clone ID 1311311) [13] showed the longest 5P-extension and
its full-length DNA sequence was determined. However, the
cDNA sequence of that clone was truncated in the 5P-region
compared to the human TK2 cDNA. We used a PCR with
primers designed from the sequence of the EST clone to am-
plify and clone the lacking 5P-region. Using this strategy, we
obtained several cDNA fragments of mouse TK2, but none of
the fragments contained an ATG start codon upstream of the
open reading frame (data not shown). The sequences of these
PCR ampli¢ed fragments were instead used for new searches
of the GenBank EST library to identify cDNA clones further
extended in the 5P-region. One clone was identi¢ed
(AU035388) with a long 5P-extension and it contained an
ATG codon in frame with the TK2 open reading frame.
The complete 1.6 kbp sequence of mouse TK2 contained an
open reading frame encoding a 270 amino acid protein with a
predicted molecular mass of 31.4 kDa (Fig. 1). The predicted
protein sequence showed W85% identity to human TK2, but
contained a 36 amino acid extended N-terminal region (Fig.
2A). Mitochondrial import signals are usually located in the
N-terminal part of the protein, form an amphipathic K-helical
structure that contains positively charged and hydrophobic
amino acid residues and lack negatively charged residues
[14]. Sequence analysis of the extended N-terminal region of
mouse TK2 showed that the region was rich in positively
charged arginine residues as well as in hydrophobic amino
acids (Fig. 2B). No negatively charged amino acids were
present among the ¢rst 30 N-terminal residues. Furthermore,
a schematic sketch of the N-terminal region as a putative K-
helix showed that the positively charged amino acid residues
were located on one side opposite to several hydrophobic
residues (Fig. 2C). These properties strongly suggest that the
N-terminal region of mouse TK2 constitutes a mitochondrial
targeting sequence. After import of the protein into the mito-
chondria, the mitochondrial targeting peptides are cleaved by
mitochondrial pre-peptide peptidases. The consensus motif for
cleavage according to the two protease model [15] was iden-
ti¢ed in the mouse TK2 N-terminal region and suggested that
the putative signal is cleaved between amino acids 24 and 25
(Fig. 2B)
3.2. Expression of mouse mitochondrial TK2 in cancer cell lines
We decided to express the cloned mouse TK2 cDNA in
mammalian cells in order to verify the mitochondrial location
of the enzyme. TK2 was expressed as a fusion protein to GFP
to visualize the protein in living cells. To avoid interference by
GFP with the mitochondrial import signal, TK2 cDNA was
cloned upstream of GFP (Fig. 3A). CHO cells were trans-
fected with plasmids expressing GFP alone, a fusion of the
mitochondrial targeting sequence of cytC and GFP or the
TK2-GFP fusion (Fig. 3B). Cells expressing GFP alone
showed homogenous green £uorescence both in the nucleus
and in the cytosol. This distribution is expected because the
low molecular mass of GFP allows for free di¡usion between
the cytosol and nucleus across the nuclear envelope. The cells
expressing cytC-GFP showed a dotted £uorescence pattern
located around a non-£uorescent nucleus. This pattern has
been shown to be typical for the mitochondrial location of
GFP [12]. The cells expressing TK2-GFP showed a similar
£uorescence pattern as the cells that expressed cytC-GFP.
Accordingly, we conclude that the cloned mouse TK2
cDNA is targeted to mitochondria.
Fig. 1. The cDNA and predicted amino acid sequences of mouse
TK2. The start and stop codons are printed in bold. A possible
poly-adenylation signal is underlined.
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4. Discussion
In the present study, we have cloned the mouse TK2 cDNA
and shown that the enzyme is targeted to the mitochondria.
This is, to our knowledge, the ¢rst report on the cDNA clon-
ing of a mitochondrial TK2. Two human TK2 cDNAs, that
di¡er in their 5P-regions, have been cloned but neither of these
cDNAs encode a mitochondrial targeting signal [8^10]. We
have made attempts using several di¡erent methodological
strategies to clone the 5P-region of human TK2 containing
the mitochondrial import signal (unpublished results). How-
ever, these attempts have not yet been successful. It is possible
that structural features of the mRNA 5P-region, such as hair-
pin loops, prevent generation of the full-length cDNA. An-
other possibility is that the previously cloned human TK2
cDNA encodes a cytosolic TK2 and that the cDNA of the
mitochondrial TK2 isoform has not yet been identi¢ed. The
existence of a cytosolic TK2 has been suggested by studies on
subcellular fractionated crude protein extracts that appear to
have a low level of enzyme activity of TK2 in the cytosolic
fraction [7]. However, there are also experimental evidences
that TK2 is exclusively located in the mitochondria. Berk and
Clayton showed that a cell line de¢cient in cytosolic TK1
activity exclusively incorporated dThd into mitochondrial
DNA [3]. These data strongly suggest that the major TK2
activity is located in the mitochondria.
The physiological consequences of a mitochondrial location
of TK2 appear to be that nucleosides and nucleoside analogs
that are phosphorylated by the enzyme become trapped within
the mitochondria [3,16]. The nucleosides and nucleoside ana-
logs can subsequently be incorporated into mitochondrial
DNA but cannot access the cytosolic/nuclear deoxyribonu-
Fig. 2. The N-terminal putative mitochondrial import signal of mouse TK2. (A) Alignment of mouse TK2 N-terminus and the previously
cloned human TK2 isoforms, named TK2a [10] and TK2b [8]. Black boxes indicate conserved amino acid residues compared to the mouse
TK2 sequence. (B) Physical properties of the N-terminal amino acid residues. H, hydrophobic; N, neutral; P, polar; +, positively charged. The
arrow indicates the probable mitochondrial pre-peptide peptidase cleavage site [15]. (C) The predicted location of the amino acid residues in an
K-helix structure.
Fig. 3. Expression of mouse TK2 as a fusion to GFP. (A) Plasmids used to express wild-type GFP (wtGFP), mitochondrial cytC-GFP and
mouse TK2 fused to GFP (TK2-GFP). CMV, cytomegalo virus promoter. (B) Fluorescence microscopy images of CHO cells transfected with
the GFP plasmids.
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cleotide pool. On the contrary, there is evidence that nucleo-
side analogs phosphorylated in the cytosol or nucleus can be
imported into the mitochondria [17] and a mitochondrial de-
oxyribonucleotide transporter protein was recently identi¢ed
[18]. Deoxyribonucleotides and phosphorylated nucleoside
analogs thus appear to be able to be imported into the mito-
chondria, but once within this compartment, they become
trapped. It is therefore likely that nucleoside analogs such
as the anti-HIV thymidine analog AZT and the anti-hepatitis
nucleoside analog 1-(2-deoxy-2-£uoro-B-D-arabinofuranosyl)-
5-iodouracil (FIAU) will stay within the mitochondria once
phosphorylated by TK2. These compound are not likely to
have therapeutic e¡ects in the mitochondrial compartment,
since viral replication occurs in the cytosol. However, both
AZT and FIAU interfere with mitochondrial DNA replica-
tion and cause delayed adverse e¡ects due to mitochondrial
dysfunction [2,19]. We recently showed that overexpression of
the mitochondrial purine nucleoside kinase, deoxyguanosine
kinase, enhances the sensitivity of cancer cells towards several
purine nucleoside analogs [20]. These data suggest that the
mitochondrial nucleoside kinases contribute to the pharmaco-
logical e¡ects of nucleoside analogs. The cloning of the mito-
chondrial isoform of TK2 will be the basis to elucidate the
role of the subcellular compartmentalization of TK2 and its
correlation to therapeutic and toxic e¡ects of pyrimidine nu-
cleoside analogs.
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